Lipitor Studies Show No Significant Benefit in Women

Ads Fail to Report Lack of Efficacy in Women

A new study that looked at the use of Pfizer's cholesterol lowering drug, Lipitor, suggests that there is no evidence of the drug reducing the risk for heart attacks in women.

Furthermore, while the Lipitor FDA-approved label does state that there is a lack of evidence of benefit in women, the Lipitor ads fail to disclose that fact.

The study, published in the Journal of Empirical Legal Studies, also states that the FDA has not requested that further studies be done to determine if there is benefit for the drug in women, even though it is prescribed to women.

The authors of study, headed by Theodore Eisenberg of Cornell Law School and Martin T. Wells of Cornell University, state that reasonably healthy women are spending billions of dollars every year on a drug that lacks the evidence to support its use in preventing heart attacks in women.

SEPT-22-08: Top-selling Cholesterol Drug Does Little For Women, Study Suggests [SCIENCE DAILY: LIPITOR DOES LITTLE FOR WOMEN]

Legal Help

If you or a loved one has suffered ill health effects or damages from misleading drug-related information, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.
Published on Sep-22-08